Article
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma.
Cancer immunology, immunotherapy : CII - 1 Apr 2006
Gatza Erin, Okada Craig Y
Abstract excerpt
There has been a recent interest in using IL-15 to enhance antitumor activity in several models because of its ability to stimulate CD8+ T cell expansion, inhibit apoptosis and promote memory T cell survival and maintenance. Previously, we reported that C6VL tumor lysate-pulsed dendritic cell vaccines significantly enhanced the survival of tumor-bearing mice by stimulating a potent tumor-specific CD8+ T cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
